• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床试验的行为动力学

The behavioral dynamics of clinical trials.

作者信息

Leventhal H, Nerenz D R, Leventhal E A, Love R R, Bendena L M

机构信息

Institute for Health, Health Care Policy, and Aging Research, Division on Health, Rutgers University, New Brunswick, New Jersey 08903.

出版信息

Prev Med. 1991 Jan;20(1):132-46. doi: 10.1016/0091-7435(91)90014-u.

DOI:10.1016/0091-7435(91)90014-u
PMID:2008422
Abstract

Two ways of approaching the design of long-term clinical trials are presented and contrasted. The first, termed the "static" view, emphasizes close adherence to formal rules of study design. The second, termed the "dynamic" view, emphasizes the behavioral aspects of patient participation in trials of long duration. The dynamic view is discussed in detail, with discussion of how recruitment of participants, random assignment to conditions, compliance with protocol, and measurement of outcomes are affected by behavioral dynamics. Data from a recently completed tamoxifen toxicity trial are used to illustrate the points and to focus the discussion of behavioral dynamics on the design of a chemoprevention trial for breast cancer using tamoxifen.

摘要

本文介绍并对比了两种进行长期临床试验设计的方法。第一种方法被称为“静态”观点,强调严格遵循研究设计的正式规则。第二种方法被称为“动态”观点,强调患者在长期试验中参与的行为方面。本文详细讨论了动态观点,并探讨了行为动态如何影响参与者的招募、条件的随机分配、方案的依从性以及结果的测量。最近完成的一项他莫昔芬毒性试验的数据被用于阐述这些要点,并将行为动态的讨论聚焦于使用他莫昔芬进行乳腺癌化学预防试验的设计上。

相似文献

1
The behavioral dynamics of clinical trials.临床试验的行为动力学
Prev Med. 1991 Jan;20(1):132-46. doi: 10.1016/0091-7435(91)90014-u.
2
Recruitment strategies for a possible tamoxifen trial.他莫昔芬可能试验的招募策略。
Prev Med. 1991 Jan;20(1):119-24. doi: 10.1016/0091-7435(91)90012-s.
3
Aspects of the science of cancer prevention trials: lessons from the conduct and planning of clinical trials of a low-fat diet intervention among women.癌症预防试验科学的若干方面:女性低脂饮食干预临床试验实施与规划的经验教训
Prev Med. 1991 Jan;20(1):147-57. doi: 10.1016/0091-7435(91)90015-v.
4
Specific compliance issues in an antiestrogen trial of women at risk for breast cancer.一项针对有乳腺癌风险女性的抗雌激素试验中的特定依从性问题。
Prev Med. 1991 Jan;20(1):125-31. doi: 10.1016/0091-7435(91)90013-t.
5
Design issues for a breast cancer chemoprevention trial.一项乳腺癌化学预防试验的设计问题。
Prev Med. 1991 Jan;20(1):101-8. doi: 10.1016/0091-7435(91)90010-2.
6
Feasibility of a telephone survey to recruit health maintenance organization members into a tamoxifen chemoprevention trial.通过电话调查招募健康维护组织成员参与他莫昔芬化学预防试验的可行性。
Cancer Epidemiol Biomarkers Prev. 1992 Jul-Aug;1(5):413-6.
7
Adherence to endocrine therapy for breast cancer.乳腺癌内分泌治疗的依从性。
Oncology. 2006;71(1-2):1-9. doi: 10.1159/000100444. Epub 2007 Mar 5.
8
Tamoxifen for the prevention of breast cancer: no.他莫昔芬用于预防乳腺癌:否。
Important Adv Oncol. 1995:175-85.
9
Breast cancer chemoprevention. Tamoxifen: current issues and future prospective.乳腺癌化学预防。他莫昔芬:当前问题与未来展望。
Cancer. 1993 Aug 1;72(3 Suppl):1032-7. doi: 10.1002/1097-0142(19930801)72:3+<1032::aid-cncr2820721315>3.0.co;2-o.
10
Planning and implementing clinical trials.
Semin Oncol Nurs. 1991 Nov;7(4):243-51. doi: 10.1016/0749-2081(91)90062-t.

引用本文的文献

1
Impact of clinical trial participation on survival in patients with castration-resistant prostate cancer: a multi-center analysis.临床试验参与对去势抵抗性前列腺癌患者生存的影响:一项多中心分析。
BMC Cancer. 2018 Apr 26;18(1):468. doi: 10.1186/s12885-018-4390-x.
2
Adjuvant Endocrine Therapy in Breast Cancer: A Novel e-Health Approach in Optimizing Treatment for Seniors (OPTIMUM): A Two-Group Controlled Comparison Pilot Study.乳腺癌辅助内分泌治疗:一种优化老年人治疗的新型电子健康方法(OPTIMUM):一项两组对照比较的试点研究。
JMIR Res Protoc. 2016 Nov 7;5(4):e199. doi: 10.2196/resprot.6519.
3
The Recruitment Experience of a Randomized Clinical Trial to Aid Young Adult Smokers to Stop Smoking without Weight Gain with Interactive Technology.
一项随机临床试验的招募经验:借助交互式技术帮助年轻成年吸烟者戒烟且不增重
Contemp Clin Trials Commun. 2016 Apr 15;2:61-68. doi: 10.1016/j.conctc.2015.12.010.
4
Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholders.未经证实的基于干细胞的干预措施以及在多个利益相关者之间达成妥协政策。
BMC Med Ethics. 2015 Nov 4;16(1):75. doi: 10.1186/s12910-015-0069-x.
5
Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907).口服 CMF 在早期乳腺癌老年女性中的持续时间、依从性和毒性(CALGB 49907 的 Adherence Companion Study 60104)。
Ann Oncol. 2012 Dec;23(12):3075-3081. doi: 10.1093/annonc/mds133. Epub 2012 Jul 5.
6
Age-specific nonpersistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: a TEAM study analysis.绝经后激素受体阳性乳腺癌患者内分泌治疗的年龄特异性非持久性:TEAM 研究分析。
Oncologist. 2012;17(1):55-63. doi: 10.1634/theoncologist.2011-0037. Epub 2011 Dec 30.
7
Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104.在 CALGB 49907 中,老年早期乳腺癌患者口服辅助化疗的依从性和持久性:依从性伴随研究 60104。
J Clin Oncol. 2010 May 10;28(14):2418-22. doi: 10.1200/JCO.2009.26.4671. Epub 2010 Apr 5.
8
Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer.吉非替尼与卡培他滨联合口服治疗转移性乳腺癌的耐受性和依从性
Breast Cancer Res Treat. 2009 Oct;117(3):615-23. doi: 10.1007/s10549-009-0366-5. Epub 2009 Mar 18.
9
Behavioural dynamics of a clinical trial of sunscreens for reducing solar keratoses in Victoria, Australia.澳大利亚维多利亚州一项关于防晒霜减少日光性角化病的临床试验的行为动力学
J Epidemiol Community Health. 1997 Dec;51(6):716-21. doi: 10.1136/jech.51.6.716.